A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Gruppo Italiano Malattie EMatologiche dell'Adulto
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
University of Chicago
M.D. Anderson Cancer Center
Massachusetts General Hospital
M.D. Anderson Cancer Center
University of Washington
City of Hope Medical Center
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Fred Hutchinson Cancer Center
Medical University of South Carolina
Mayo Clinic
Columbia University
Weill Medical College of Cornell University
M.D. Anderson Cancer Center
Medical College of Wisconsin
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center